Multiple Assemblies exist for SMTL entry 7g00
Crystal Structure of human FABP1 in complex with 2-[[3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl]cyclopentene-1-carboxylic acid; X-RAY DIFFRACTION 2.60 Å

	SMTL ID 7g00.1 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.2 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.3 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.4 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.5 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.6 Ligands THIOCYANATE ION; 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.7 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.8 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.9 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.10 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.11 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.12 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.13 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.14 Ligands THIOCYANATE ION; 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.15 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer
	SMTL ID 7g00.16 Ligands 2-{[(3P)-3-(5-tert-butyl-1,2,4-oxadiazol-3-yl)-4,5,6,7-tetrahydro-1-benzothiophen-2-yl]carbamoyl}cyclopent-1-ene-1-carboxylic acid; THIOCYANATE ION Polypeptides Fatty acid-binding protein, liver Oligo-state monomer